ReviewCurrent reviews in musculoskeletal medicine2026
When an Isolated Bankart Repair is Not Enough: Comparing Latarjet Versus Augmentation with Remplissage.
Review in Current reviews in musculoskeletal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewIncreased recurrence rates following isolated arthroscopic Bankart repair, particularly in young, high-risk athletes, have prompted adoption of adjunctive surgical strategies. Two commonly utilized techniques are arthroscopic Bankart repair with Remplissage and the Latarjet procedure. Despite widespread use of both options, the optimal indications remain debated. This review synthesizes contemporary evidence regarding indications, clinical scenarios and outcomes, recurrence risk, return to sport and complication profiles following these procedures. RECENT
findingsBoth arthroscopic Bankart repair with remplissage and Latarjet demonstrate excellent outcomes, providing return to sport rates exceeding 80% with recurrence rates ranging from 5 to 10% and 0-5% for the remplissage and Latarjet, respectively [1-3]. Overall complication rates following remplissage have been reported at approximately 1.6% of cases, whereas complication rates range from 5.1 to 16.1% following Latarjet procedures [4, 5]. Recurrent instability following labral repair with remplissage is over 6-fold more likely than following Latarjet when glenoid bone loss exceeds 15% [6]. When addressing patients with recurrent shoulder instability, glenoid and humeral bone loss must be critically analyzed. In patients with subcritical glenoid bone loss who remain at elevated risk for recurrent instability, particularly young, high-demand athletes, arthroscopic Bankart repair with remplissage provides durable stabilization with recurrence rates comparable to Latarjet. However, in the setting of critical glenoid bone loss or true bipolar off-track pathology, the Latarjet procedure confers superior mechanical stability and significantly reduces the risk of recurrence and revision surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.